Bio-Rad
 |
|
| Public | |
| Traded as | : BIO S&P 400 Component |
| Industry |
Life science Clinical Diagnostics |
| Founded | 1952 |
| Founders | David and Alice Schwartz |
| Headquarters | Hercules, California, U.S.A. |
|
Area served
|
Worldwide |
|
Key people
|
Norman Schwartz (CEO) |
| Revenue |
 US$2.1 billion (FY 2013)
|
|
US$295 million (FY 2011)
|
|
 US$178 million (FY 2011)
|
|
| Total assets |
US$3.711 billion (FY 2015)
|
| Total equity |
US$1.744 billion (FY 2010)
|
|
Number of employees
|
7,800+ |
| Website | www |
Norman Schwartz (CEO)
John Goetz (Chief Operating Officer)
Giovanni Magni (Chief Strategy Officer)
Christine Tsingos (Executive Vice President, CFO)
Michael Crowley (Executive Vice President, Global Commercial Operations)
Shannon Hall (Executive Vice President, President Life Sciences Group)
John Hertia (Executive Vice President, President Clinical Diagnostics Group)
Ronald Hutton (Vice President, Treasurer)
Bio-Rad Laboratories, Inc. was founded in 1952 in Berkeley, California. The company was initially engaged in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. Today, Bio-Rad manufactures and supplies life science research, healthcare, analytical chemistry, and other markets with products and systems used to separate complex chemical and biological materials and to identify, analyze, and purify their components.
Bio-Rad operates in two industry segments: Life Science and Clinical Diagnostics. Both segments operate worldwide. Bio-Rad's customers include hospitals, major research institutions, public health, commercial laboratories, Biotechnology and Pharmaceutical Companies,and Food Safety. Bio-Rad's headquarters are in Hercules, California. The company has offices and facilities worldwide and more than 7,750 employees. Bio-Rad had revenues of more than two billion dollars in 2011. The company has been listed on the since October 24, 2008. Before that, Bio-Rad was listed on the .
Life science researchers use a variety of products and systems — including reagents, instruments, software, and apparatus — to advance drug discovery, biotechnology, food pathogen testing, and the study of life processes, primarily within a laboratory setting. Bio-Rad’s products are based on technologies used to separate, purify, identify, analyze, and amplify biological and chemical materials.
The Life Science Group provides a wide range of laboratory instruments, apparatus, and consumables used for research in functional genomics, proteomics, and food safety. The company holds leadership positions in eletrophoresis, protein assays, BSE (or mad cow disease) and CWD (chronic wasting disease) testing, gel image analysis, DNA amplification, and biochromatography. The primary end users in Bio-Rad’s sectors of the market are universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, and food testing laboratories.
...
Wikipedia